Overview
The fund is managed with a indexed approach and is distinguished by its broad diversification, minimal tracking error, and cost-effective management.
Strategy indices deliberately deviate from market capitalization in their weighting in order to capture factor premiums or reduce the investment risk.
MSCI Switzerland IMI Minimum Volatility Index is a strategy index that determines the portfolio with the least volatility from the stocks of the parent MSCI index.
The index has historically shown lower realized volatility and lower beta relative to the MSCI parent index, with a bias toward stocks in smaller companies, less volatile stocks, and stocks with lower idiosyncratic risks.
The fund is passively managed.
Benefits
Easy access to a broadly diversified portfolio of Swiss Equities.
Provides access to the performance of the index with a single transaction.
The fund is transparent and cost-effective and is liquid under normal market conditions.
You do not pay any federal stamp duty.
Risks
Features
| Product category |
Equity Switzerland |
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Day of inception |
November 3, 2016
|
| Currency of account |
CHF
|
| Close of financial year |
February 28
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.27% p.a.
|
| Flat fee |
0.22% p.a.
|
| Management fee |
0.22% p.a.
|
| Total expense ratio (TER) |
0.25% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI Switzerland IMI Minimum Volatility (TR) in CHF
|
| Cut-Off Time |
14:00h(CET)
|
| Securities no. |
33416151
|
| ISIN |
CH0334161517
|
| Bloomberg Ticker |
CSSMVQA SW
|
| Reuters Id |
33416151X.CHE
|
Performance and Prices
Percentage growth
as of April 23, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 3.59 | 5.03 | 4.73 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 15.47 | 16.45 | 32.08 |
| 3Y | |||
| 5Y | 31.82 | 58.69 | 54.23 |
| ø p.a.5Y | 5.68 | 9.68 | 9.05 |
Current data
| Net asset value | 23.04.2026 | CHF 2,095.85 |
| High - last 12 months | 27.02.2026 | CHF 2,165.09 |
| Low - last 12 months | 25.09.2025 | CHF 1,870.16 |
| Assets of the unit class in mn | 23.04.2026 | CHF 11.19 |
| Total product assets in mn | 23.04.2026 | CHF 110.34 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 31.03.2026 | 9.71% | 11.22% |
| Sharpe Ratio | 31.03.2026 | 0.89 | 0.47 |
| Risk Free Rate | 31.03.2026 | 0.46% | 0.40% |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| Novartis AG | 9.79 |
| Zurich Insurance Group AG | 8.63 |
| Nestle SA | 8.43 |
| Swisscom AG | 7.53 |
| Roche Holding AG | 6.13 |
| ABB Ltd | 5.30 |
| Chocoladefabriken Lindt & Spruengli AG | 3.76 |
| Schindler Holding AG | 3.67 |
| Swiss Prime Site AG | 3.59 |
| Alcon AG | 3.17 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|